| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Department of Comparative Medicine* and Washington National Primate Research Center, University of Washington, Seattle; the Department of Immunobiology, Amgen Corporation, Seattle; and Amnis Corporation, Seattle, Washington
Patients with inflammatory bowel disease (IBD) are at increased risk for developing high-grade dysplasia and colorectal cancer. Animal IBD models that develop dysplasia and neoplasia may help elucidate the link between inflammation and colorectal cancer. Mdr1a–/– mice lack the membrane efflux pump p-glycoprotein and spontaneously develop IBD that can be modulated by infection with Helicobacter sp: H. bilis accelerates development of colitis while H. hepaticus delays disease. In this study, we determined if H. hepaticus infection could prevent H. bilis-induced colitis. Unexpectedly, a proportion of dual-infected mdr1a–/– mice showed IBD with foci of low- to high-grade dysplasia. A group of dual-infected mdr1a–/– animals were maintained long term (39 weeks) by intermittent feeding of medicated wafers to model chronic and relapsing disease. These mice showed a higher frequency of high-grade crypt dysplasia, including invasive adenocarcinoma, possibly because H. hepaticus, in delaying the development of colitis, allows time for transformation of epithelial cells. Colonic epithelial preparations from co-infected mice showed increased expression of c-myc (5- to 12-fold) and interleukin-1
/ß (600-fold) by real-time polymerase chain reaction relative to uninfected wild-type and mdr1a–/– animals. This animal model may have particular relevance to human IBD and colorectal cancer because certain human MDR1 polymorphisms have been linked to ulcerative colitis and increasedrisk for colorectal cancer.
This article has been cited by other articles:
 |
|
 |
|
  T. Poutahidis, K. M. Haigis, V. P. Rao, P. R. Nambiar, C. L. Taylor, Z. Ge, K. Watanabe, A. Davidson, B. H. Horwitz, J. G. Fox, et al. Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma Carcinogenesis, December 1, 2007; 28(12): 2614 - 2623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Venkatesan, P. M. Treuting, E. D. Fuller, R. E. Goldsby, T. H. Norwood, T. A. Gooley, W. C. Ladiges, B. D. Preston, and L. A. Loeb Mutation at the Polymerase Active Site of Mouse DNA Polymerase {delta} Increases Genomic Instability and Accelerates Tumorigenesis Mol. Cell. Biol., November 1, 2007; 27(21): 7669 - 7682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. An, B. Wei, B. Xia, J. M. McDaniel, T. Ju, R. D. Cummings, J. Braun, and L. Xia Increased susceptibility to colitis and colorectal tumors in mice lacking core 3 derived O-glycans J. Exp. Med., June 11, 2007; 204(6): 1417 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Whary, S. J. Danon, Y. Feng, Z. Ge, N. Sundina, V. Ng, N. S. Taylor, A. B. Rogers, and J. G. Fox Rapid Onset of Ulcerative Typhlocolitis in B6.129P2-IL10tm1Cgn (IL-10-/-) Mice Infected with Helicobacter trogontum Is Associated with Decreased Colonization by Altered Schaedler's Flora Infect. Immun., December 1, 2006; 74(12): 6615 - 6623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Pratt, K. L. Sachen, H. D. Wood, K. A. Eaton, and V. B. Young Modulation of Host Immune Responses by the Cytolethal Distending Toxin of Helicobacter hepaticus. Infect. Immun., August 1, 2006; 74(8): 4496 - 4504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Maggio-Price, P. Treuting, W. Zeng, M. Tsang, H. Bielefeldt-Ohmann, and B. M. Iritani Helicobacter Infection Is Required for Inflammation and Colon Cancer in Smad3-Deficient Mice Cancer Res., January 15, 2006; 66(2): 828 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Rush Vet. Pathol., September 1, 2005; 42(5): 677 - 678. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
